Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Approaching April 2019 and no cash left and having lost a term sheet, a licensing deal looks less and less likely. This is not because of "manipulators" or any other conspiracy. The remaining pipeline (B and K) just isn't as proven and as attractive as it might need to be to attract strong interest. Management has been very optimistic, and has expressed that optimism. But true interest in our pipeline from objective sources, while difficult, is a much better gauge. The dropped term sheet, languishing share price, and difficulty raising affordable capital from even pharma-experienced investors or bio-cap funds are our only independent indications. They don't bode well.

Rooting for Leo!